The top medical device companies in the world made more than $542.6 million in general payments to physicians and hospitals in 2018, according to an analysis of Medical Design & Outsourcing‘s Big 100 and CMS Open Payments data. Zimmer Biomet topped the list with $109.4 million in general payments* to physicians and teaching hospitals in […]
Medtronic Q2 results beat The Street
Medtronic (NYSE:MDT) posted second-quarter results today that beat the consensus forecast on Wall Street and reiterated its outlook for the rest of the fiscal year. The Fridley, Minn.–based company reported profits of $1.4 billion, or $1.01 per share, on sales of $7.7 billion for the three months ended Oct. 25, 2019, for a bottom-line gain of […]
This injectable electrode could lower the cost of neuromodulation therapy
Researchers at the University of Wisconsin-Madison have developed an injectable, flexible electrode that could replace rigid nerve-stimulating implants and reduce the cost of neuromodulation therapy. The researchers’s new type of electrode can be injected as a liquid and cure within the body. Traditional neuromodulation treatments require surgically implanted devices that can cost up to six […]
Avita Medical appoints new CFO
Avita Medical (ASX:AVH) yesterday announced it appointed David McIntyre as chief financial officer, effective Nov. 18. McIntyre will be responsible for overseeing global finance and investor relations. He replaces interim CFO Tim Rooney, who will continue as the company’s chief administrative officer. “David’s extensive background in global finance, operations and law, in combination with his experience […]
Axonics slides on earnings, misses on revenue in Q3 results
Axonics Modulation Technologies (NSDQ:AXNX) posted third-quarter results today that missed the consensus forecast on Wall Street. The Irvine, Calif.-based company posted losses of $25 million, or -89¢ per share, on sales of $1.3 million for the three months ended Sept. 30, 2019, for a bottom-line loss of 228.9% sales growth of 546.8% compared with Q3 2018. […]
Owlstone Medical partners with Thermo Fisher Scientific for breath biopsies
Owlstone Medical last week announced that it has forged a partnership with Thermo Fisher Scientific‘s (NYSE:TMO) to advance non-invasive breath sampling in disease detection. Through the agreement, both companies will integrate the Thermo Scientific Q Exactive GC Hybrid Quadrupole-Orbitrap MassSpectrometer into Owlstone Medical’s Breath Biopsy platform. The collaboration will hopefully qualify the mass analyzer for detecting biomarkers […]
iRhythm Technologies won’t file 10-Q, citing material weaknesses
iRhythm Technologies (NSDQ:IRTC) this week said it would not be filing its quarterly report on Form 10-Q, citing previously disclosed material weaknesses, according to an SEC filing. The San Francisco-based company said it identified errors that affected prior periods while preparing the quarterly report for the period ended Sept. 30, 2019. The errors could affect the […]
Making your GCP questions easier
Toni Hegyi, Manager, Quality Assurance at IMARC Research, Inc. No matter where you land on the clinical research spectrum, chances are you have encountered some challenges with interpreting and/or implementing Good Clinical Practice (GCP) guidelines. With so many trial designs and research settings, it can be difficult to know how to appropriately apply GCP and […]
Electromed beats The Street in Q1 results
Electromed (NSDQ:ELMD) posted first-quarter results today that beat the consensus forecast on Wall Street. The New Prague, Minn.-based company reported profits of $1 million, or 12¢ per share, on sales of $8.3 million for the three months ended Sept. 30, 2019, for a bottom-line gain of 536.1% sales growth of 13.7% compared with Q1 2019. Adjusted […]
ICU Medical posts Street-beating Q3 results
ICU Medical (NSDQ:ICUI) posted third-quarter results today that beat the consensus on Wall Street. The San Clemente, Calif.-based company reported profits of $26.6 million, or $1.24 per share, on sales of $307.5 million for the three months ended Sept. 30, 2019, for a bottom-line gain of 12046.1% sales loss of -6% compared with Q3 2018. Adjusted […]
SmileDirectClub beats The Street in Q3 results
SmileDirectClub (NSDQ:SDC) posted third-quarter results that beat the consensus on Wall Street. The Nashville, Tenn.-based company reported losses of -$387.6 million, or -89¢ per share, on sales of $180.2 million for the three months ended Sept. 30, 2019, for a bottom-line gain of 2484% sales growth of 50.5% compared with Q3 2018. Adjusted to exclude one-time […]
- 1
- 2
- 3
- …
- 83
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
YouTube